Bile duct cancer is a disease where cancerous cells form in the tissues of the bile duct. The bile duct is part of a network of tubes that connect the liver, gallbladder, pancreas, and small intestine ...

Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led to ...

About 8,000 people are diagnosed with bile duct cancer each year. But the actual number of cases is likely to be higher, because these cancers can be hard to diagnose, and some might be misclassified ...

Certain foods can exacerbate symptoms of bile duct cancer. People may find relief by avoiding those foods, such as processed foods. A dietitian can also help create an appropriate eating plan. The ...

The FDA approved Imfinzi with gemcitabine and cisplatin for advanced biliary tract cancer based on the TOPAZ-1 trial results. The trial showed improved overall survival of 12.8 months with Imfinzi ...

An international multicentre trial involving UK researchers has demonstrated that a new personalised cancer treatment can radically improve the outlook for some patients with bile duct cancer. In ...

Bile duct cancer, or cholangiocarcinoma, is a serious concern due to its rapid progression and often mild, easily mistaken ...

Approval of the Taiho drug, futibatinib, covers adults with intrahepatic cholangiocarcinoma, a rare cancer affecting the bile ducts of the liver. Many genetic variants can drive the progression of ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA on Wednesday granted accelerated approval to zanidatamab ...

Biliary tract cancer (BTC), a rare malignancy that grows within the bile ducts and gallbladder, grows very aggressively. The fast progression associated with BTC makes it challenging to treat and ...

Please provide your email address to receive an email when new articles are posted on . Researchers reported a 41% confirmed ORR among patients with HER2-positive disease. No patients with ...